Trials / Completed
CompletedNCT00653198
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
Hospital-based, Case-control Study to Assess the Vaccine Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 March 2006 and at Least 12 Weeks of Age, in Panama
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 885 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Weeks
- Healthy volunteers
- Not accepted
Summary
This study aims to estimate the effectiveness of Rotarix™ vaccine which is used nationwide as a part of the expanded program on immunization (EPI), in preventing RV SGE among hospitalised children born after 1 March 2006, which corresponds to the date of introduction of Rotarix™ in the national immunization program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention |
Timeline
- Start date
- 2008-03-19
- Primary completion
- 2011-03-18
- Completion
- 2011-03-18
- First posted
- 2008-04-04
- Last updated
- 2017-09-05
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT00653198. Inclusion in this directory is not an endorsement.